Article Figures & Data
Figures
- Figure 1.
Survival analysis curves showing the decline in the nonclozapine group compared with the clozapine group. From the DCD, the clozapine group had a longer period in the community upon release before the first conviction.
- Figure 2.
Survival curves for the two medication groups showing time in months from first release date to DCD or date of first nonviolent conviction.
- Figure 3.
Survival curves for clozapine showing a longer time interval between the release date and the DCD or first conviction for a violent act.
- Figure 4.
Survival curves for clozapine showing shorter time interval than other medications between the release date and the DCD or first conviction for a sex crime.
Tables
- Table 1
Reconviction Rates for Four Offense Categories Comparing the Study Groups Throughout the Period of Follow-up
Categories of Reconviction Clozapine (n = 41) Nonclozapine (n = 21) Fisher's Exact Test P Any/all offenses 21 (51.2) 11 (52.4) 0.572 Nonviolent 19 (46.3) 9 (42.9) 0.505 Violent 13 (31.7) 7 (33.3) 0.558 Sexual 8 (19.5) 2 (9.5) 0.265 Data are the number (percentage of group).
- Table 2
Reconviction Rates for Four Offense Categories Comparing the Study Groups With a 2-Year Follow-up Period
Categories of Reconviction Clozapine (n = 41) Nonclozapine (n = 21) Fisher's Exact Test p Any/all offenses 10 (24.4) 9 (42.9) 0.115 Nonviolent 10 (24.4) 6 (28.6) 0.474 Violent 5 (12.2) 6 (28.6) 0.108 Sexual 4 (9.8) 1 (4.8) 0.444 Data are the number (percentage of group).
- Table 3
Mean Difference Between the Date of Release and the Date of First Reconviction for All Categories
Offense Category Clozapine − Nonclozapine (months) Confidence Interval Any reconviction 10.2 −5.4 to 25.9 Nonviolent 7.05 −7.7 to 21.9 Violent 21.3 −4.9 to 47.6 Sexual 8.6 −15.2 to 32.3
